UNIV DEGLI STUDI DI PAVIA has a total of 20 patent applications. It decreased the IP activity by 25.0%. Its first patent ever was published in 2006. It filed its patents most often in WIPO (World Intellectual Property Organization), EPO (European Patent Office) and United States. Its main competitors in its focus markets foods and drinks, pharmaceuticals and biotechnology are NKD PHARMA CO LTD, WU JIE and FMC BIOPOLYMER AS.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 11 | |
#2 | EPO (European Patent Office) | 4 | |
#3 | United States | 2 | |
#4 | Australia | 1 | |
#5 | China | 1 | |
#6 | Italy | 1 |
# | Industry | |
---|---|---|
#1 | Foods and drinks | |
#2 | Pharmaceuticals | |
#3 | Biotechnology | |
#4 | Medical technology | |
#5 | Environmental technology |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Microorganisms | |
#3 | Object sterilising | |
#4 | Peptides | |
#5 | Enzymes | |
#6 | Therapeutic chemical compounds | |
#7 | Special foods | |
#8 | Bakery products | |
#9 | Foods | |
#10 | Climate change adaptation technologies |
# | Name | Total Patents |
---|---|---|
#1 | Maggi Maristella | 6 |
#2 | Scotti Claudia | 6 |
#3 | Rossi Silvia | 3 |
#4 | Auricchio Ferdinando | 3 |
#5 | Ferrari Franca | 3 |
#6 | Bonferoni Maria Cristina | 3 |
#7 | Sandri Giuseppina | 3 |
#8 | Marconi Stefania | 2 |
#9 | Gerace Dario | 2 |
#10 | Benazzo Marco | 2 |
Publication | Filing date | Title |
---|---|---|
WO2020245013A1 | Artificial neural network on quantum computing hardware | |
WO2020234098A1 | Electro-optic modulator with periodic p-n junction in slow-light waveguide gratings | |
WO2020202018A1 | System for the determination of the surface and mechanical characteristics of filamentary structures, in particular skin appendages, structures associated therewith, natural or synthetic fibers and their aggregates | |
EP3799891A1 | 3d-patterned fiber material for the topical delivery of nucleic acid and the process for its preparation | |
WO2020058749A1 | An antibody drug fusion based on asparaginase | |
WO2020053627A1 | Targeted single domain antibodies with catalytic activity (t-can) | |
WO2019138266A1 | Diagnostic and prognostic method for myelofibrosis | |
WO2019021325A1 | Electrospun nanofibers and membrane | |
WO2018196965A1 | Manufacture of ceramic objects by 3d-printing | |
CN110462035A | Highly stable and antiprotease Colaspase | |
WO2018024312A1 | Surgical instrument for introducing a cochlear implant | |
EP3113768A1 | Use of arylalkanolamines as sigma-1 receptor antagonists |